# FDA Inspection 1037566 - Swati Spentose Private Limited - January 12, 2018

Source: https://www.keypedia.com/records/fda_inspections/swati-spentose-private-limited/1dd87200-a2dc-4098-a73c-baa579e151c7
Source feed: FDA_Inspections

> FDA Inspection 1037566 for Swati Spentose Private Limited on January 12, 2018. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1037566
- Company Name: Swati Spentose Private Limited
- Inspection Date: 2018-01-12
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1245668 - 2024-05-31](https://www.keypedia.com/records/fda_inspections/swati-spentose-private-limited/e84ee402-ee7a-4f05-81ac-aa46529103c5)
- [FDA Inspection 1076313 - 2018-12-12](https://www.keypedia.com/records/fda_inspections/swati-spentose-private-limited/89f273ce-a3f8-4952-a9a9-976bc164c820)
- [FDA Inspection 967302 - 2016-02-26](https://www.keypedia.com/records/fda_inspections/swati-spentose-private-limited/7b4eda11-eab6-4d93-8e64-f5ccde650a1f)

Company: https://www.keypedia.com/companies/swati-spentose-private-limited/829926c8-b657-4a0d-ae81-83501694ede3

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c